相似文献
1
Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France.
Nat Med. 2020 Nov;26(11):1801. doi: 10.1038/s41591-020-1129-4.
2
Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
Nat Rev Immunol. 2020 Oct;20(10):644. doi: 10.1038/s41577-020-00430-w.
3
Author Correction: Detection of SARS-CoV-2 in nasal swabs using MALDI-MS.
Nat Biotechnol. 2020 Oct;38(10):1211. doi: 10.1038/s41587-020-0701-2.
4
Author Correction: Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care.
Sci Rep. 2020 Aug 12;10(1):13892. doi: 10.1038/s41598-020-70939-6.
5
Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Nat Commun. 2020 Oct 20;11(1):5409. doi: 10.1038/s41467-020-19339-y.
6
Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.
Sci Data. 2020 Jul 17;7(1):247. doi: 10.1038/s41597-020-00589-w.
7
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
Nat Med. 2020 Sep;26(9):1494. doi: 10.1038/s41591-020-1058-2.
8
Author Correction: SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
Nat Struct Mol Biol. 2020 Nov;27(11):1094. doi: 10.1038/s41594-020-00533-x.
9
Author Correction: Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands.
Nat Med. 2020 Nov;26(11):1802. doi: 10.1038/s41591-020-1128-5.
10
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.
Nat Immunol. 2020 Oct;21(10):1302. doi: 10.1038/s41590-020-0788-0.
引用本文的文献
1
Optimal control of the COVID-19 pandemic: controlled sanitary deconfinement in Portugal.
Sci Rep. 2021 Feb 10;11(1):3451. doi: 10.1038/s41598-021-83075-6.
Zotero 插件